Evonik enters agreement to produce silk proteins for AMSilk

Evonik announced today that it entered into an agreement with AMSilk to produce sustainable silk proteins.

AMSilk, a Germany-based biotech company, develops innovative, sustainable silk proteins. The uses of the silk include a broad range of applications including medical devices. They provide optimal performance and minimal environmental impact, according to a news release.

Essen, Germany-based Evonik’s agreement covers the production of industrial quantities of the silk proteins. Evonik plans to produce the silk at its contract development and manufacturing (CDMO) precision fermentation site in Slovakia.

“Working with a partner who puts sustainability at the heart of their business is in perfect alignment with our goals at Evonik. We are delighted to partner with AMSilk to bring smart biotech silk materials to industries worldwide,” said Thomas Riermeier, head of the Health Care business line at Evonik.

AMSilk turns man-made proteins into …

Read more
  • 0

Evonik acquires JeNaCell and its nanostructured biomaterial

Evonik (Essen, Germany) recently announced that has purchased JeNaCell and its nanostructured biomaterial for wound dressings and dermatology.

The financial terms of the deal were not disclosed.

JeNaCell (Jena, Germany) provides biotechnologically derived cellulose. Evonik first invested in the startup in 2015.

“JeNaCell has developed one of the most innovative biomaterials for medical device technologies. With the help of the creativity and expertise of JeNaCell’s specialists, we will ensure that even more patients benefit from these products in the future,” said Thomas Riermeier, head of Evonik’s Health Care business line, said in an Aug. 2 news release. “The acquisition will help us to further strengthen our position as an innovation hub for the world’s leading medical technology companies.”


Read more
  • 0